Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296678657> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4296678657 endingPage "e048" @default.
- W4296678657 startingPage "e048" @default.
- W4296678657 abstract "Introduction: Infantile hemangiomas are common vascular tumours in infants. Propranolol is currently accepted as the first choice if systemic treatment is needed. Propranolol has an excellent record of safety in young children, but some concerns have been raised about possible longer-term neurocognitive effects and five recent unexpected infant deaths have been reported. An alternative beta blocker, atenolol, may be as effective at hemangioma treatment and may have a better side effect profile. Objectives: To report the efficacy, safety, and side effect profile of oral atenolol for infantile hemangiomas. Design: We conducted a prospective observational study of 219 infants with infantile hemangiomas who were prescribed oral atenolol (1 mg/kg bd) as outpatients. The primary outcome measure was the response of the hemangioma. Results: The median age at commencement was 3.6 months. The median duration of treatment was 8.5 months. An excellent response was seen in 59.0% of patients, good response in 30.5%, and poor response in 10.5%. There was no significant difference in the response to atenolol with location or type of hemangioma or age at the commencement of atenolol. Possible side effects were reported in 8% of patients, and sleep disturbance in 3%. No infant had any reported hypoglycaemic or cardiovascular events attributable to atenolol. Conclusion: Atenolol is effective in treating infantile hemangiomas in an outpatient setting with 90% of patients having a good or excellent response to treatment. Atenolol appears to have a more favorable side effect profile than propranolol. It is reasonable to consider atenolol as first-line therapy for infantile hemangiomas needing oral treatment." @default.
- W4296678657 created "2022-09-23" @default.
- W4296678657 creator A5015300197 @default.
- W4296678657 creator A5057906736 @default.
- W4296678657 creator A5078153354 @default.
- W4296678657 creator A5083272980 @default.
- W4296678657 date "2022-09-22" @default.
- W4296678657 modified "2023-10-14" @default.
- W4296678657 title "Evaluating the Use of Atenolol for the Treatment of Infantile Hemangiomas" @default.
- W4296678657 cites W1808100106 @default.
- W4296678657 cites W1996111172 @default.
- W4296678657 cites W2045034709 @default.
- W4296678657 cites W2100584705 @default.
- W4296678657 cites W2434290088 @default.
- W4296678657 cites W2587981590 @default.
- W4296678657 cites W2593538788 @default.
- W4296678657 cites W2767110082 @default.
- W4296678657 cites W2895078012 @default.
- W4296678657 cites W2903448447 @default.
- W4296678657 cites W2916945571 @default.
- W4296678657 cites W3111989817 @default.
- W4296678657 cites W3153466827 @default.
- W4296678657 cites W4200395061 @default.
- W4296678657 cites W4205129736 @default.
- W4296678657 doi "https://doi.org/10.1097/jova.0000000000000048" @default.
- W4296678657 hasPublicationYear "2022" @default.
- W4296678657 type Work @default.
- W4296678657 citedByCount "0" @default.
- W4296678657 crossrefType "journal-article" @default.
- W4296678657 hasAuthorship W4296678657A5015300197 @default.
- W4296678657 hasAuthorship W4296678657A5057906736 @default.
- W4296678657 hasAuthorship W4296678657A5078153354 @default.
- W4296678657 hasAuthorship W4296678657A5083272980 @default.
- W4296678657 hasBestOaLocation W42966786571 @default.
- W4296678657 hasConcept C126322002 @default.
- W4296678657 hasConcept C141071460 @default.
- W4296678657 hasConcept C187212893 @default.
- W4296678657 hasConcept C199360897 @default.
- W4296678657 hasConcept C2776525901 @default.
- W4296678657 hasConcept C2778151854 @default.
- W4296678657 hasConcept C2780191036 @default.
- W4296678657 hasConcept C2908629526 @default.
- W4296678657 hasConcept C3019900241 @default.
- W4296678657 hasConcept C3454156 @default.
- W4296678657 hasConcept C41008148 @default.
- W4296678657 hasConcept C42219234 @default.
- W4296678657 hasConcept C71924100 @default.
- W4296678657 hasConcept C84393581 @default.
- W4296678657 hasConceptScore W4296678657C126322002 @default.
- W4296678657 hasConceptScore W4296678657C141071460 @default.
- W4296678657 hasConceptScore W4296678657C187212893 @default.
- W4296678657 hasConceptScore W4296678657C199360897 @default.
- W4296678657 hasConceptScore W4296678657C2776525901 @default.
- W4296678657 hasConceptScore W4296678657C2778151854 @default.
- W4296678657 hasConceptScore W4296678657C2780191036 @default.
- W4296678657 hasConceptScore W4296678657C2908629526 @default.
- W4296678657 hasConceptScore W4296678657C3019900241 @default.
- W4296678657 hasConceptScore W4296678657C3454156 @default.
- W4296678657 hasConceptScore W4296678657C41008148 @default.
- W4296678657 hasConceptScore W4296678657C42219234 @default.
- W4296678657 hasConceptScore W4296678657C71924100 @default.
- W4296678657 hasConceptScore W4296678657C84393581 @default.
- W4296678657 hasIssue "4" @default.
- W4296678657 hasLocation W42966786571 @default.
- W4296678657 hasLocation W42966786572 @default.
- W4296678657 hasOpenAccess W4296678657 @default.
- W4296678657 hasPrimaryLocation W42966786571 @default.
- W4296678657 hasRelatedWork W1467851610 @default.
- W4296678657 hasRelatedWork W2025993981 @default.
- W4296678657 hasRelatedWork W2035366826 @default.
- W4296678657 hasRelatedWork W2047407909 @default.
- W4296678657 hasRelatedWork W2131887917 @default.
- W4296678657 hasRelatedWork W2332155469 @default.
- W4296678657 hasRelatedWork W2990008070 @default.
- W4296678657 hasRelatedWork W3002671326 @default.
- W4296678657 hasRelatedWork W3166677356 @default.
- W4296678657 hasRelatedWork W3176226672 @default.
- W4296678657 hasVolume "3" @default.
- W4296678657 isParatext "false" @default.
- W4296678657 isRetracted "false" @default.
- W4296678657 workType "article" @default.